<?xml version="1.0" encoding="UTF-8"?>
<p>The world is now facing a pandemic of COVID-19, for which no proven specific therapies are available, other than supportive care. In China, France, Spain, and Italy, a large number of patients have received compassionate use therapies. These therapies have been mostly given without controls, except for a few randomized trials initiated in China, and more recently in the US (
 <xref rid="B46" ref-type="bibr">46</xref>). In the 2014 Ebola outbreak, a randomized clinical trial was implemented and successfully launched during the outbreak; however, it was too late for the trials to be completed in time to be helpful to the currently or soon-to-be infective population (
 <xref rid="B47" ref-type="bibr">47</xref>). In our view, this tragedy cannot be repeated. The COVID-19 pandemic is catastrophic, even though different countries have implemented strict control measures.
</p>
